Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain : Identification of Potential Relevant Biomarkers
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain : Identification of Potential Relevant Biomarkers
For each patient in the study, blood, and pain scores will be collected to look for markers for pain, at the start of treatment and 6 months after surgery of treatment.
The study is investigator-initiated, prospective, study. There will be no change in care.
Patients who have had a diagnosis of IC made by cystoscopy and hydrodistension and still have pain will be recruited for this study.
Patients will have blood samples taken at the visit they sign the consent form and 6 months later.
The study staff will call and remind the patient of their 6 month visit.
Inclusion Criteria:
Exclusion Criteria: